KRAS and colorectal carcinoma: Genome-scale DNA methylation profiling of 125 CRC cases revealed that CIMP-high tumours have high BRAF mutations (61%), whereas CIMP-low tumours rarely have mutant BRAF, but is associated with high KRAS mutations (45%).